News & Press Releases |
Press Release: October 6th, 2020
Acquist Therapeutics to Present at 2020 BIO Investor Forum
Press Release: May 27, 2020
Acquist Therapeutics Announces New Appointments to its Board of Directors
Press Release: April 21, 2020
Acquist Therapeutics Expands Patent Portfolio for Novel Small Molecules, Receives Fourth U.S. Composition Patent
Press Release: October 16, 2019
Acquist Therapeutics to Present at 2019 BIO Investor Forum
Press Release: January 17, 2019
Acquist Announces Issuance of Two U.S. Patents Covering its Drug Library of Novel Small Molecules
Press Release: October 2, 2018
Acquist Therapeutics to Present Scientific Results for Lead Clinical Drug in Gout | Abstract
Press Release: September 25, 2018
Acquist Therapeutics to Provide Update on Lead Programs for Treating NASH and Gout
Press Release: October 11, 2017
Relburn-Metabolomics to Present Developments in Lead Programs for NASH and Gout
Press Release: October 6, 2017
Relburn-Metabolomics Appoints Renowned Experts in Nonalcoholic Steatohepatitis (NASH) to its Scientific Advisory Board
Press Release: October 20, 2015
Relburn-Metabolomics to Outline Research Progress at BIO Investor Forum
Press Release: June 9, 2015
Relburn-Metabolomics to Present at BIO International 2015
Press Release: January 7, 2015
Relburn-Metabolomics to Present at Biotech Showcase 2015
Press Release: October 6, 2014
Relburn-Metabolomics to Report Scientific Progress and Clinical Plans for Anti-Gout Program at Two Major Conferences | Abstract
Press Release: January 7, 2014
Relburn-Metabolomics to Outline Clinical Development Plans for Lead Anti-Gout Product
Copyright © 2021 Acquist Theraputics, Inc.®
Website by CreatedByEric